Fairdeal Corporation

Market Cap (₹ Cr.)

₹7,881

52 Week High

658.85

Book Value

₹129

52 Week Low

378.20

PE Ratio

24.89

PB Ratio

3.44

PE for Sector

37.00

PB for Sector

3.92

ROE

9.78 %

ROCE

18.55 %

Dividend Yield

0.00 %

EPS

₹19.31

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Indian - Bulk Drugs & Formln

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

11.51 %

Net Income Growth

57.39 %

Cash Flow Change

42.52 %

ROE

48.70 %

ROCE

43.50 %

EBITDA Margin (Avg.)

31.22 %

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Revenue	231	272	273	231	251	277	296	225	265	251	316	261	297	299	283	266	284	347	370	350	374	334	394	368	334	468	427	354	348	512	475	425	441	560	507	478	475	652	540
Expenses	177	197	198	179	186	202	197	183	196	201	215	197	242	217	215	199	231	263	271	235	304	204	266	263	274	331	324	298	319	413	395	360	377	410	401	370	396	482	433
EBITDA	54	75	75	51	66	75	99	42	70	49	101	64	55	82	68	68	53	83	99	115	69	130	128	104	59	137	103	57	29	99	80	65	64	150	106	107	79	170	107
Operating Profit %	18 %	23 %	22 %	18 %	24 %	24 %	30 %	17 %	22 %	15 %	30 %	21 %	11 %	24 %	20 %	21 %	14 %	22 %	21 %	26 %	8 %	33 %	29 %	21 %	12 %	26 %	18 %	13 %	5 %	16 %	11 %	11 %	13 %	23 %	16 %	18 %	13 %	23 %	14 %
Depreciation	9	8	9	8	8	8	8	9	9	9	9	8	8	9	9	7	8	9	10	9	9	9	10	9	9	10	9	9	9	9	10	10	10	10	10	10	10	11	14
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1
Profit Before Tax	45	66	66	43	57	66	90	33	61	40	92	56	47	73	59	60	45	73	89	105	59	120	118	94	49	127	93	47	19	89	69	54	53	139	95	96	67	158	92
Tax	11	19	18	11	16	19	25	11	12	12	26	14	15	22	17	16	12	22	26	30	5	31	27	19	8	31	19	15	3	24	18	12	15	31	22	20	13	36	20
Net Profit	34	47	48	32	41	49	67	22	49	29	65	43	32	51	43	44	34	52	63	73	58	91	91	71	42	100	74	32	14	73	51	39	37	109	72	78	48	115	74
EPS in ₹	1.91	2.46	2.70	1.80	2.33	2.75	3.77	1.24	2.76	1.65	3.65	2.40	1.77	2.93	2.47	2.51	1.93	3.00	3.64	4.26	3.40	5.30	5.33	4.18	2.49	5.93	4.36	1.87	0.85	4.37	3.07	2.38	2.24	6.54	4.36	4.81	2.97	7.06	4.55

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,140	1,259	1,459	1,488	1,625	1,806	1,943	2,254	2,335	2,459
Fixed Assets	381	671	674	670	678	670	685	701	695	676
Current Assets	498	520	703	708	729	923	924	989	1,024	1,055
Capital Work in Progress	29	20	6	13	12	24	19	104	198	261
Investments	272	325	491	472	585	665	790	886	806	850
Other Assets	457	243	287	333	349	447	448	563	637	672
Total Liabilities	210	182	196	225	192	264	221	306	355	361
Current Liabilities	186	162	177	207	177	245	202	271	311	308
Non Current Liabilities	24	20	18	18	16	19	19	35	44	54
Total Equity	930	1,077	1,264	1,262	1,433	1,542	1,722	1,949	1,981	2,097
Reserve & Surplus	912	1,059	1,246	1,245	1,416	1,525	1,705	1,932	1,964	2,081
Share Capital	18	18	18	18	18	17	17	17	17	16

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	-10	1	10	-2	-6	12	-1	5	-11	1
Investing Activities	-89	-73	-144	20	-109	-85	-84	-147	4	-18
Operating Activities	127	171	153	148	104	239	210	162	165	221
Financing Activities	-47	-97	0	-169	-0	-142	-126	-10	-180	-202

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024
Promoter	69.35 %	69.35 %	69.35 %	69.36 %	69.36 %	69.50 %	69.50 %	69.50 %	69.50 %	69.50 %	69.66 %	69.66 %	69.66 %	69.66 %	69.66 %
FIIs	5.71 %	4.76 %	4.51 %	4.47 %	4.52 %	4.34 %	3.99 %	3.77 %	3.80 %	2.06 %	2.42 %	2.43 %	2.65 %	2.51 %	2.62 %
DIIs	4.02 %	4.48 %	4.65 %	5.45 %	5.86 %	6.08 %	6.77 %	7.76 %	8.27 %	9.12 %	8.12 %	7.76 %	6.94 %	6.73 %	6.03 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	20.92 %	21.40 %	21.48 %	20.72 %	20.27 %	20.09 %	19.74 %	18.98 %	18.43 %	19.32 %	19.80 %	20.15 %	20.76 %	21.10 %	21.70 %

Show % Change

Dividend History

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,795.30	4,26,517.78	38.05	49,887.17	12.06	9,648	27.35	44.59
Cipla	1,486.50	1,18,365.23	25.64	26,520.66	14.17	4,155	12.95	41.66
Mankind Pharma	2,551.60	1,02,273.02	48.35	10,615.63	19.57	1,942	28.89	44.48
Dr Reddys Laboratories	1,214.45	99,671.43	18.67	28,905.40	12.36	5,578	-9.47	36.74
Zydus Life Science	949.05	95,013.64	22.21	19,831.50	13.82	3,831	14.57	33.61
Lupin	2,071.35	93,214.31	35.49	20,141.50	19.94	1,936	73.52	42.68
Aurobindo Pharma	1,223.70	71,496.23	19.60	29,559.25	17.55	3,169	8.65	19.57
Alkem Laboratories	5,583.35	66,992.27	30.81	12,978.42	9.84	1,811	14.16	39.72
Glenmark Pharmaceuticals	1,478.20	41,349.03	-	12,653.09	6.58	-1,831	675.84	30.06
IPCA Laboratories	1,591.35	39,912.75	59.43	7,829.81	22.92	529	80.05	55.08